Perspectives on Vascular Closure Device and the Latest Evidence
Perspectives on Vascular Closure Device and the Latest Evidence
Perspectives on Vascular Closure Device and the Latest Evidence
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<str<strong>on</strong>g>Perspectives</str<strong>on</strong>g> <strong>on</strong> <strong>Vascular</strong> <strong>Closure</strong> <strong>Device</strong>s<br />
Meta-analysis: VCDs Vs. MC Post Percutaneous Procedures<br />
When <strong>the</strong>y repeated <strong>the</strong> analysis <strong>on</strong>ly in<br />
trials with explicit intenti<strong>on</strong> to treat<br />
analysis, <strong>the</strong> RR of hematoma was<br />
higher in <strong>the</strong> VCD group (1.89;95%<br />
CI=1.13-3.15) in 4 trials involving 404<br />
pts in VCD <strong>and</strong> 259 pts in MC group.<br />
The RR of developing pseudoaneurysm<br />
was also higher in <strong>the</strong> VCD group (5.40,<br />
95% CI=1.21-24.5). The authors<br />
c<strong>on</strong>cluded that “<strong>the</strong>re is <strong>on</strong>ly marginal<br />
evidence that VCD are effective <strong>and</strong><br />
<strong>the</strong>re is reas<strong>on</strong> for c<strong>on</strong>cern that <strong>the</strong>se<br />
devices MAY increase <strong>the</strong> risk of<br />
hematoma <strong>and</strong> pseudoaneurysm.”<br />
Koreny M et al JAMA2004;291:350-7
Change language